FUNDING CANCER - Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (Multiple Mechanisms)
Sponsor: National Institutes of Health
Multiple Mechanisms:
PAR-23-254, R01 Clinical Trial Not Allowed
PAR-23-255, R21 Clinical Trial Not Allowed
Description: The National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data.
- Next Application Deadline: October 5, 2024
-
Future Deadlines:
-
October 16, 2024
- February 5, 2025
- February 16, 2025
- June 5, 2025
- June 16, 2025
- October 5, 2025
- October 16, 2025
- February 5, 2026
- February 16, 2026
- June 5, 2026
- June 16, 2026
To view all current UVACCC funding opportunities, please click here.
For all open cancer-related funding opportunities, please click here.